Cramer on BloggingStocks: No worries at JPMorgan


TheStreet.com's Jim Cramer says the bank has the least to worry about and can gain from new federal regulation.

Sometimes you just have to step back from the small-picture hubbub and make some assumptions about the new landscape if legislation passes.

If you look at the health care legislation you know that it is going to cut out some profitability for companies that have relied on the government for big profits, which means the companies that have the most Medicare exposure. So you go with the health maintenance company with the least Medicare exposure -- WellPoint (NYSE: WLP) (Cramer's Take). It simply can't get hit as badly as a Humana (NYSE: HUM) (Cramer's Take) or a UnitedHealth (NYSE: UNH) (Cramer's Take) because it doesn't have the exposure.

That's how I feel about JPMorgan Chase (NYSE: JPM) (Cramer's Take) when it comes to banking. It's not a hedge fund seeking to fight regulation, it is not a thrift hoping to arbitrage legislation, it is not a credit card issuer trying to get a loophole going and it isn't a consumer protection racket or a consumer defrauder. It is, in this world, a good actor.

This "sweeping" federal regulation will have lots of ramifications through the industry, but from what I can see JPMorgan has the least to worry about and it will have the most to gain if others are driven out of business.

We are seeing patterns here that are pretty evident: If you need government help, you are going to pay dearly. If you don't need government help, you are going to do better -- not great -- but better than if you do need help.

This regime takes some getting used to because the previous regime's mantra was to give taxpayer gifts to public companies. This regime either wants to take back the gifts or make you pay for them yourself. So the more self-reliant, such as WellPoint and JPMorgan, the better they will do.

Jim Cramer is co-founder and chairman of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. At the time of publication, Cramer was long JPMorgan.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 13, 2012: 02:04 AM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    DailyFinance BlackBerry App

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    BioHealth Investor Headlines

    Page Loaded in 1329116685201 ms.